# Oncosem Onkolojik Sistemler, 2026 yılı 3. dönem faaliyet raporunu yayımladı

- Bağlantı: https://www.borsatek.com/oncsm-2026-3-donem-faaliyet-raporu/
- Yayımlanma: 2026-11-09T18:20:42+03:00
- Yazar: Haber Merkezi

Reklam

 [ ⌊Stablex Kare Banner⌉ ](https://track.adform.net/C/?bn=91045298;gdpr=${GDPR};gdpr_consent=${GDPR_CONSENT_50})

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. (ONCSM), 2026 yılı 3. dönemine
ait faaliyet raporunu yayımladı.

Şirketten KAP’a gönderilen bildirime göre, rapor 2026 yılı 9 aylık ara dönem için
hazırlandı. Bildirimin ayrıntılarına, ekli faaliyet raporundan erişilebilir.

📎 Bildirim Ekleri

[📄Oncosem Faaliyet Raporu 30092026.pdfPDF](https://www.borsatek.com/kap-git/?u=aHR0cHM6Ly93d3cua2FwLm9yZy50ci90ci9hcGkvZmlsZS9kb3dubG9hZC80MDI4MzI4ZGExN2U1MTVmMDFhMWFiMGU4YmE1NmFjNw)

Bildirim Eki Sayfaları

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 1](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p01.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 2](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p02.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 3](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p03.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 4](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p04.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 5](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p05.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 6](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p06.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 7](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p07.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 8](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p08.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 9](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p09.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 10](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p10.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 11](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p11.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 12](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p12.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 13](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p13.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 14](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p14.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 15](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p15.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 16](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p16.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 17](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p17.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 18](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p18.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 19](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p19.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 20](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p20.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 21](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p21.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 22](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p22.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 23](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p23.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 24](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p24.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 25](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p25.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 26](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p26.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 27](https://i1.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p27.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 28](https://i3.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p28.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 29](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p29.webp)

![Oncosem Faaliyet Raporu 30092026.pdf — sayfa 30](https://i2.wp.com/www.borsatek.
com/app/uploads/2026/11/kap-4028328da17e515f01a1ab0e8ba56ac7-p30.webp)

 |  Faaliyet Raporu |  
 |  Yapılan Açıklama Düzeltme mi? |  Hayır (No) |  
 |  Konuya İlişkin Daha Önce Yapılan Açıklamanın Tarihi |  – |  
 |  Açıklamalar |  
 |  Bildirim İçeriği |  
 |

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. 2026 Yılı 3. Dönemine ait Faaliyet Raporudur.

İşbu açıklamamızın İngilizce çevirisi ekte yer almakta olup, açıklama metinlerinde herhangi bir farklılık olması durumunda, Türkçe açıklama esas kabul edilecektir.

Activity Report of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. for the Third Quarter of 2026

The English translation of this disclosure is attached hereto. In case of any discrepancy between the Turkish and English versions of the disclosure, the Turkish version shall prevail.

  |